13 November 2020 - Announcement marks the seventh cancer type for which PD-L1 IHC 22C3 pharmDx has gained approval in the ...
9 November 2020 - On 6 November, the FDA approved the FoundationOne Liquid CDx test as a companion diagnostic device to ...
4 November 2020 - The application from Biogen has requested consideration of two alternative methods for the detection of the presence ...
30 October 2020 - 16 agenda items for 26-27 November 2020 meeting. ...
29 October 2020 - The new FDA approval allows the test to be used as a companion diagnostic for a broad ...
27 October 2020 - Foundation Medicine today announced that the U.S. FDA approved FoundationOne Liquid CDx for three new companion ...
23 October 2020 - Detection of genomic alterations that drive the growth and spread of the tumour can guide treatment decisions ...
8 September 2020 - Comprehensive pan-tumour liquid biopsy test analyzes >300 cancer-associated genes and multiple genomic signatures to inform treatment choices. ...
8 September 2020 - CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for Gavreto. ...
24 August 2020 - In its August 23 Emergency Use Authorisation for COVID-19 convalescent plasma for the treatment of hospitalised ...
7 August 2020 - Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses ...
27 January 2020 - Final decision provides new access to Next Generation Sequencing tests for certain Medicare patients with cancer ...
10 July 2019 - On 20 June 2019, for the first time, the German Federal Joint Committee (G-BA), made the resolution ...
6 December 2018 - One challenge we face right now, when it comes to developing diagnostics that can help target ...
4 December 2018 - The U.S. FDA today took a significant step forward in driving the efficient development of novel diagnostic ...